Ballentine Partners’s Royalty Pharma RPRX Stock Holding History

Ballentine Partners’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$366K	Sell
2025 Q2	$387K	Buy
2025 Q1	$242K	Sell
2024 Q4	$200K	Buy
2024 Q2	–	Sell
2024 Q1	$381K	Buy
2023 Q4	$341K	Buy
2022 Q2	–	Sell
2022 Q1	$504K	Buy
2021 Q4	$363K	Buy